Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

Point of Care (PoC) molecular diagnostics market is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics market growth.

According to our (Global Info Research) latest study, the global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market size was valued at USD 3665.8 million in 2022 and is forecast to a readjusted size of USD 6128.6 million by 2029 with a CAGR of 7.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Quick and precise detection of causative agents is of utmost importance in infectious disease emergency cases as the inaccuracy in disease detection leads to incorrect treatment which escalates disease spreading risk. Point of care molecular diagnostic assays permit the timely detection of the causative agent enabling effective disease control.

This report is a detailed and comprehensive analysis for global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Atlas Genetics, Cepheid, Fluxergy and Roche Diagnostics. etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Real Time PCR
    DNA/RNA Purification

Market segment by Application
    Hospitals
    Ambulatory Surgical Centers
    Diagnostic Centers

Market segment by players, this report covers
    Abbott Laboratories
    Atlas Genetics
    Cepheid
    Fluxergy
    Roche Diagnostics

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics, with revenue, gross margin and global market share of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics from 2018 to 2023.
Chapter 3, the Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics.
Chapter 13, to describe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics by Type
        1.3.1 Overview: Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type in 2022
        1.3.3 Real Time PCR
        1.3.4 DNA/RNA Purification
    1.4 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market by Application
        1.4.1 Overview: Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals
        1.4.3 Ambulatory Surgical Centers
        1.4.4 Diagnostic Centers
    1.5 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size & Forecast
    1.6 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast by Region
        1.6.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region, (2018-2029)
        1.6.3 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Prospect (2018-2029)
        1.6.4 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Prospect (2018-2029)
        1.6.6 South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Abbott Laboratories
        2.1.1 Abbott Laboratories Details
        2.1.2 Abbott Laboratories Major Business
        2.1.3 Abbott Laboratories Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
        2.1.4 Abbott Laboratories Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Abbott Laboratories Recent Developments and Future Plans
    2.2 Atlas Genetics
        2.2.1 Atlas Genetics Details
        2.2.2 Atlas Genetics Major Business
        2.2.3 Atlas Genetics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
        2.2.4 Atlas Genetics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Atlas Genetics Recent Developments and Future Plans
    2.3 Cepheid
        2.3.1 Cepheid Details
        2.3.2 Cepheid Major Business
        2.3.3 Cepheid Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
        2.3.4 Cepheid Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Cepheid Recent Developments and Future Plans
    2.4 Fluxergy
        2.4.1 Fluxergy Details
        2.4.2 Fluxergy Major Business
        2.4.3 Fluxergy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
        2.4.4 Fluxergy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Fluxergy Recent Developments and Future Plans
    2.5 Roche Diagnostics
        2.5.1 Roche Diagnostics Details
        2.5.2 Roche Diagnostics Major Business
        2.5.3 Roche Diagnostics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
        2.5.4 Roche Diagnostics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Roche Diagnostics Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics by Company Revenue
        3.2.2 Top 3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Players Market Share in 2022
        3.2.3 Top 6 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Players Market Share in 2022
    3.3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market: Overall Company Footprint Analysis
        3.3.1 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market: Region Footprint
        3.3.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market: Company Product Type Footprint
        3.3.3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application (2018-2023)
    5.2 Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2018-2029)
    6.2 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2018-2029)
    6.3 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country
        6.3.1 North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2018-2029)
        6.3.2 United States Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)
        6.3.3 Canada Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)
        6.3.4 Mexico Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2018-2029)
    7.2 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2018-2029)
    7.3 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country
        7.3.1 Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2018-2029)
        7.3.2 Germany Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)
        7.3.3 France Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)
        7.3.5 Russia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)
        7.3.6 Italy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Region
        8.3.1 Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Region (2018-2029)
        8.3.2 China Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)
        8.3.3 Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)
        8.3.4 South Korea Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)
        8.3.5 India Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)
        8.3.7 Australia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2018-2029)
    9.2 South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2018-2029)
    9.3 South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country
        9.3.1 South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2018-2029)
        9.3.2 Brazil Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)
        9.3.3 Argentina Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size by Country
        10.3.1 Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2018-2029)
        10.3.2 Turkey Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)
        10.3.4 UAE Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Drivers
    11.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Restraints
    11.3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Industry Chain
    12.2 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Upstream Analysis
    12.3 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Midstream Analysis
    12.4 Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Abbott Laboratories Company Information, Head Office, and Major Competitors
    Table 6. Abbott Laboratories Major Business
    Table 7. Abbott Laboratories Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
    Table 8. Abbott Laboratories Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Abbott Laboratories Recent Developments and Future Plans
    Table 10. Atlas Genetics Company Information, Head Office, and Major Competitors
    Table 11. Atlas Genetics Major Business
    Table 12. Atlas Genetics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
    Table 13. Atlas Genetics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Atlas Genetics Recent Developments and Future Plans
    Table 15. Cepheid Company Information, Head Office, and Major Competitors
    Table 16. Cepheid Major Business
    Table 17. Cepheid Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
    Table 18. Cepheid Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Cepheid Recent Developments and Future Plans
    Table 20. Fluxergy Company Information, Head Office, and Major Competitors
    Table 21. Fluxergy Major Business
    Table 22. Fluxergy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
    Table 23. Fluxergy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Fluxergy Recent Developments and Future Plans
    Table 25. Roche Diagnostics Company Information, Head Office, and Major Competitors
    Table 26. Roche Diagnostics Major Business
    Table 27. Roche Diagnostics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Product and Solutions
    Table 28. Roche Diagnostics Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Roche Diagnostics Recent Developments and Future Plans
    Table 30. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue (USD Million) by Players (2018-2023)
    Table 31. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Share by Players (2018-2023)
    Table 32. Breakdown of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 33. Market Position of Players in Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 34. Head Office of Key Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Players
    Table 35. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market: Company Product Type Footprint
    Table 36. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market: Company Product Application Footprint
    Table 37. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics New Market Entrants and Barriers to Market Entry
    Table 38. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Mergers, Acquisition, Agreements, and Collaborations
    Table 39. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (USD Million) by Type (2018-2023)
    Table 40. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Share by Type (2018-2023)
    Table 41. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Forecast by Type (2024-2029)
    Table 42. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2018-2023)
    Table 43. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Forecast by Application (2024-2029)
    Table 44. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
    Table 45. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
    Table 46. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
    Table 47. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
    Table 48. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
    Table 49. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
    Table 50. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
    Table 51. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
    Table 52. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
    Table 53. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
    Table 54. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
    Table 55. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
    Table 56. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
    Table 57. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
    Table 58. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
    Table 59. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
    Table 60. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
    Table 61. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Region (2024-2029) & (USD Million)
    Table 62. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
    Table 63. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
    Table 64. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
    Table 65. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
    Table 66. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
    Table 67. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
    Table 68. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
    Table 69. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
    Table 70. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
    Table 71. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
    Table 72. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
    Table 73. Middle East & Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
    Table 74. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Raw Material
    Table 75. Key Suppliers of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Raw Materials
List of Figures
    Figure 1. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Picture
    Figure 2. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type in 2022
    Figure 4. Real Time PCR
    Figure 5. DNA/RNA Purification
    Figure 6. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application in 2022
    Figure 8. Hospitals Picture
    Figure 9. Ambulatory Surgical Centers Picture
    Figure 10. Diagnostic Centers Picture
    Figure 11. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Market Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 14. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Region (2018-2029)
    Figure 15. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Region in 2022
    Figure 16. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 17. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 18. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 19. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 20. Middle East and Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 21. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Revenue Share by Players in 2022
    Figure 22. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 23. Global Top 3 Players Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share in 2022
    Figure 24. Global Top 6 Players Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share in 2022
    Figure 25. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Share by Type (2018-2023)
    Figure 26. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share Forecast by Type (2024-2029)
    Figure 27. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Share by Application (2018-2023)
    Figure 28. Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Share Forecast by Application (2024-2029)
    Figure 29. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type (2018-2029)
    Figure 30. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application (2018-2029)
    Figure 31. North America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Country (2018-2029)
    Figure 32. United States Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 33. Canada Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 34. Mexico Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 35. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type (2018-2029)
    Figure 36. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application (2018-2029)
    Figure 37. Europe Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Country (2018-2029)
    Figure 38. Germany Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 39. France Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 40. United Kingdom Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 41. Russia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 42. Italy Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 43. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type (2018-2029)
    Figure 44. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application (2018-2029)
    Figure 45. Asia-Pacific Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Region (2018-2029)
    Figure 46. China Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 47. Japan Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 48. South Korea Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 49. India Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 50. Southeast Asia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 51. Australia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 52. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type (2018-2029)
    Figure 53. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application (2018-2029)
    Figure 54. South America Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Country (2018-2029)
    Figure 55. Brazil Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 56. Argentina Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 57. Middle East and Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Type (2018-2029)
    Figure 58. Middle East and Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Application (2018-2029)
    Figure 59. Middle East and Africa Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value Market Share by Country (2018-2029)
    Figure 60. Turkey Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 61. Saudi Arabia Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 62. UAE Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 63. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Drivers
    Figure 64. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Restraints
    Figure 65. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics in 2022
    Figure 68. Manufacturing Process Analysis of Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics
    Figure 69. Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Companies Mentioned

Abbott Laboratories
Atlas Genetics
Cepheid
Fluxergy
Roche Diagnostics